News

July 19, 2017July 19, 2017

35 Therapies in Phase 2 and 3 Clinical Trials Raise Hopes in Alzheimer’s Community

Alzheimer’s research is gaining momentum, with 27 Phase 3 and eight Phase 2 clinical trials either in progress or expected over the next five years. The good news surfaced in ... Read more

July 18, 2017

Phase 2/3 Trial of AXS-05 for Alzheimer’s Agitation Enrolls First Patient

News

Axsome Therapeutics has announced that the first patient was enrolled in the ADVANCE-1 Phase 2/3 trial evaluating the effectiveness and safety of its investigative therapy AXS-05 for the treatment of agitation in Alzheimer’s ... Read more

July 17, 2017July 17, 2017

Chronic Lack of Sleep May Raise Risk of Alzheimer’s Disease, Study Suggests

News

A poor night’s sleep may increase the levels of proteins associated with Alzheimer’s disease, say researchers, noting that their findings may be especially important for people with chronic sleep ... Read more

July 15, 2017

ANK1 Expression Change May Cause Neuroinflammation

News

Expression of the protein ANK1 (ankyrin repeat domain-containing protein) is four fold higher in the microglia of patients with Alzheimer’s disease (AD). Microglia are a type of immune cell found ... Read more

July 14, 2017July 14, 2017

E-Scape Bio Hits $63 Million in Financing to Develop Alzheimer’s Therapy

News

E-Scape Bio, the Gladstone Institutes’ spin-off company working to develop therapies for neurodegenerative disorders such as Alzheimer’s disease, announced that it has raised a total of $63 million in Series A ... Read more

July 13, 2017

2017 Alzheimer Award Goes to Shi-Jiang Li for Developing CARE Index

News

Prof. Shi-Jiang Li, PhD, is the recipient of the 2017 Alzheimer Award granted every year by the associate editors of the Journal of Alzheimer’s Disease (JAD). Li was singled ... Read more

July 12, 2017

Strawberry Compound Fisetin Slows Cognitive Decline of Aging in Mouse Study

News

Researchers fed the antioxidant fisetin, found in strawberries and other fruits and vegetables, to mice for seven months and found that the compound partially protected the animals from age-associated cognitive ... Read more

July 11, 2017July 13, 2017

Axovant to Present New Results on Intepirdine and Nelotanserin Research Programs

News

New results from its intepirdine (RVT-101) and nelotanserin research programs on Alzheimer’s disease (AD) and Lewy body dementia will be shared soon, Axovant Sciences announced. The data will be presented at ... Read more

July 10, 2017

Moderate but Not Low-intensity Exercise Might Help Protect Brain from Alzheimer’s

News

People at risk for Alzheimer’s disease who spend more time doing moderate-intensity exercise have a healthier level of glucose metabolism in the brain — considered a reflection of how healthy ... Read more

July 7, 2017July 7, 2017

Alzheimer’s Disease Patients with Psychosis Misdiagnosed at Higher Rates than Previously Thought, Study Finds

News

Patients with Alzheimer’s disease who experience delusions and hallucinations are five times more likely to be misdiagnosed than Alzheimer’s patients without psychosis, new research from St. Michael’s Hospital in Toronto, Canada, ... Read more